HUTT to Assess Cardiac Autonomic Nervous Function
ConditionAutonomic Nervous System Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-85
SponsorThe First Hospital of Hebei Medical University
About this trial
Autonomic nervous system diseases can cause abnormalities in the circulatory system, leading to malignant arrhythmia and sudden cardiac death. Standardized, operable, and simplified diagnostic indicators are urgently needed to evaluate autonomic nervous function, particularly cardiac autonomic nervous function. The investigators use HUTT in order to provide data support for cardiac autonomic nervous system evaluation.
Eligibility criteria
Qualifiers
Vertical tilt test and 24-hour holter electrocardiogram were performed at the same time
Receive treatment in our hospital.
Disqualifiers
Taking benzodiazepines or hypotensive drugs within 24 hours
Combined with mental illness, severe dementia, serious organ disease
Severe arrhythmia, deep breathing and poor coordination of Valsaval movements affected the interpretation of results.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov